Ute Mercker and Mike Schüßl discuss start-up support in Berlin, IBB Ventures’ funding criteria, campus hubs for life sciences and AI, and why bio:cap is launching at the perfect time.
Prof. Dr. med. Eicke Latz is one of Europe’s most influential immunologists and a leading figure in translational biomedical research. As Founder and Scientific Director of the German Rheumatology Research Center (DRFZ) and Professor of Experimental Rheumatology at Charité Berlin, he has dedicated his career to understanding the immune system — and turning that knowledge into real therapeutic breakthroughs.
In this interview, he discusses what Europe needs to become a global powerhouse in life sciences, why now is the ideal moment to launch a platform like bio:cap, and how AI is reshaping drug development and diagnostics.